Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 100% increase over the number of companies inspected in the previous year, when three companies received three inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics, Veterinary, and Biologics sectors. The second most common type of company inspected period worked in the Devices sector.
There were four companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Great Lakes Growers | Food and Cosmetics | 05/30/2024 | No Action Indicated (NAI) |
Rothenbuhler Cheesemakers, Inc. | Food and Cosmetics | 06/12/2024 | No Action Indicated (NAI) |
Rothenbuhler Cheesemakers, Inc. | Veterinary | 06/12/2024 | No Action Indicated (NAI) |
Stembanc Holdings, Inc. | Biologics | 06/06/2024 | No Action Indicated (NAI) |
Stembanc, Inc. | Biologics | 06/06/2024 | No Action Indicated (NAI) |
Troy Innovative Instruments, Inc. | Devices | 07/26/2024 | Voluntary Action Indicated (VAI) |
What The Raw | Veterinary | 01/22/2024 | Official Action Indicated (OAI) |